Background: Globally, the prevalence of Crohn’s disease (CD), an inflammatory bowel disease (IBD), has been rising. The occurrence has been more prevalent over the past few decades, particularly among young children in Middle Eastern nations. This case report aims to increase awareness of the typical CD presentation in children and add the possibility of IBD to the list of diagnoses for suspected cases.
Case Presentation: Our patient was identified as having CD based on the clinical, laboratory, imaging, and enteroscopy with biopsy. After that, he began treating the patient with 2 g of mesalazine taken orally once daily, and added 50 mg of azathioprine, the patient’s symptoms and laboratory results improved. After taking immunosuppressive drugs for 6 months, he got a coronavirus disease 2019 infection that worsened the patient’s condition.
Conclusion: By raising awareness of early CD diagnosis and beginning therapy based on histopathological reports and the results of colonoscopy and enteroscopy, complications can be avoided and thus improve patients’ quality of life.
Key words: Crohn’s disease (CD), inflammatory bowel disease (IBD), COVID-19, coronavirus.
|
